This investment will support seven research teams from across the country that will study the microbiome to better understand its contribution to childhood asthma, cervical cancer, diabetes, youth inflammatory bowel disease, and maternal malnutrition.

A message from President Ed McCauley

"Now we're listed on the big board in the TSX," says Trevor Peters, CEO of Willow Biosciences.

Direct-C Limited ("Direct-C") is pleased to announce that it has secured a CAD$1.25 million equity financing round and has closed the first tranche of the investment.